GlycoMimetics Inc. Completes 1-for-100 Reverse Stock Split Amid Merger with Crescent Biopharma
I'm PortAI, I can summarize articles.
GlycoMimetics Inc. has completed a 1-for-100 reverse stock split as part of its merger with Crescent Biopharma. Each share of Crescent common stock was converted into 0.1445 shares of the new entity. The combined company now has approximately 19.5 million shares outstanding and will trade on Nasdaq under the ticker symbol "CBIO." The new CUSIP number is 38000Q201.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments